Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 1041Neoplasms 872Prostatic Neoplasms 506Lung Neoplasms 421Colorectal Neoplasms 357Motor Activity 219Head and Neck Neoplasms 194Uterine Cervical Neoplasms 189Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 173Pancreatic Neoplasms 160Ovarian Neoplasms 138Colonic Neoplasms 137Carcinoma, Hepatocellular 136Anxiety Disorders 124Rectal Neoplasms 117Hematologic Neoplasms 114Multiple Myeloma 106Stomach Neoplasms 103Neoplasm Metastasis 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 87Endometrial Neoplasms 86Glioblastoma 84Disease 83Lymphoma 81Sarcoma 78

Interventions

Methotrexate 1Leucovorin 1Dactinomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hydatidiform Mole, Invasive × 1 year × Clear all
NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Peking Union Medical College Hospital

Phase NA Active not recruiting
228 enrolled
Gynecologic

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡